Both Metformin and Pristiq offer similar effectiveness in symptom control, with the main difference being how quickly they act. Either drug is a viable option depending on the patient’s needs.

Metformin has fewer side effects and is less likely to interact with other medications, making it a safer choice for sensitive patients.

Pristiq has a more stable therapeutic effect and is less likely to lead to dependency or cravings compared to Metformin.

Both Metformin and Pristiq are easy to use, with straightforward dosing regimens that ensure good adherence.

Metformin has fewer contraindications, making it suitable for a broader range of patients, including those with comorbidities.

Both drugs offer advantages depending on treatment goals. Metformin is great for fast relief, while Pristiq is better for long-term management. The choice depends on the patient’s specific needs.